🇺🇸 FDA
Patent

US 8648067

Substituted phenoxypropylcycloamine derivatives as histamine-3 (H3) receptor ligands

granted A61PA61P11/00A61P25/00

Quick answer

US patent 8648067 (Substituted phenoxypropylcycloamine derivatives as histamine-3 (H3) receptor ligands) held by Teva Sante expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Teva Sante
Grant date
Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61P, A61P11/00, A61P25/00, A61P25/06, A61P25/08